158 related articles for article (PubMed ID: 31949793)
1. Elevated CTSL2 expression is associated with an adverse prognosis in hepatocellular carcinoma.
Jing J; Wang S; Ma J; Yu L; Zhou H
Int J Clin Exp Pathol; 2018; 11(8):4035-4043. PubMed ID: 31949793
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
4. Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients.
Yang H; Xu M; Chi X; Yan Q; Wang Y; Xu W; Zhuang K; Li A; Liu S
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):554-563. PubMed ID: 28363424
[TBL] [Abstract][Full Text] [Related]
5. [Expression of ZNF207 in hepatocellular carcinoma and its significance].
Zhou C; Li N
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 44(4):406-412. PubMed ID: 31113916
[TBL] [Abstract][Full Text] [Related]
6. Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis.
Zhou H; Wang SC; Ma JM; Yu LQ; Jing JS
Med Sci Monit; 2018 Aug; 24():6021-6028. PubMed ID: 30157168
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
9. TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma.
Tian F; Xu J; Xue F; Guan E; Xu X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28546230
[TBL] [Abstract][Full Text] [Related]
10. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
[TBL] [Abstract][Full Text] [Related]
11. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of carbonic anhydrase XII (CA XII) overexpression in hepatocellular carcinoma.
Gu XF; Shi CB; Zhao W
Int J Clin Exp Pathol; 2019; 12(6):2173-2183. PubMed ID: 31934040
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
[TBL] [Abstract][Full Text] [Related]
14. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
[TBL] [Abstract][Full Text] [Related]
15. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of contactin 1 in human hepatocellular carcinoma.
Li GY; Huang M; Pan TT; Jia WD
Onco Targets Ther; 2016; 9():387-94. PubMed ID: 26855587
[TBL] [Abstract][Full Text] [Related]
17. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
[TBL] [Abstract][Full Text] [Related]
18. Association between the expression of carbonic anhydrase II and clinicopathological features of hepatocellular carcinoma.
Zhang H; Zhuo C; Zhou D; Zhang F; Chen M; Xu S; Chen Z
Oncol Lett; 2019 Jun; 17(6):5721-5728. PubMed ID: 31186798
[TBL] [Abstract][Full Text] [Related]
19. Expression of LAMP3 and its correlation with clinicopathologic characteristics and prognosis in hepatocellular carcinoma.
Gui Y; Liu WB; Chen H; Ma JL; Li JS
Int J Clin Exp Pathol; 2018; 11(1):367-374. PubMed ID: 31938120
[TBL] [Abstract][Full Text] [Related]
20. Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma.
Sheng XR; Xing SG; Wang RD; Chen K; Jia WD
Onco Targets Ther; 2018; 11():909-917. PubMed ID: 29503566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
